2022
NAFTNet retrospective report on the treatment of anti-Ro/SSA mediated fetal heart block with dexamethasone
Sunderji S, Peyvandi S, Jaeggi E, Szwast A, Ryan G, Tessier F, Siddiqui S, Cuneo B, Sheth S, Treadwell M, Frommelt M, Turan S, Copel J, Emery S, Rand L, Moon-Grady AJ, Network F. NAFTNet retrospective report on the treatment of anti-Ro/SSA mediated fetal heart block with dexamethasone. The Journal Of Maternal-Fetal & Neonatal Medicine 2022, 35: 9263-9270. PMID: 35014577, DOI: 10.1080/14767058.2022.2025536.Peer-Reviewed Original ResearchConceptsPositive pregnanciesPrimary outcomePregnancy complicationsPregnancy outcomesPremature deliverySecondary outcomesNorth American Fetal Therapy Network (NAFTNet) centersRo/SSA-positive pregnanciesRetrospective multi-center cohort studyAnti-Ro/SSAMulti-center cohort studyFetal heart blockOverall pregnancy complicationsBetter pregnancy outcomesPoor pregnancy outcomesUse of dexamethasoneTerms of efficacyHigh rateFetal dyadsMaternal comorbiditiesAntibody positivityExpectant managementMaternal diseaseNeonatal morbidityPreterm delivery
1990
Invasive Fetal Assessment by Fetal Blood Sampling
Copel J, Grannum P. Invasive Fetal Assessment by Fetal Blood Sampling. 1990, 31-43. DOI: 10.1007/978-1-4612-3380-0_3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsFetal blood samplingFetal circulationBlood samplingMaternal-fetal medicineReal-time ultrasoundPregnancy lossFetal assessmentPhysical examMaternal bloodFetal bloodPerinatal medicineFetal patientsPatientsHigh rateBloodLaboratory testsMedicineInternistsFetusesPlacentocentesisDiagnosisFetoscopyCirculation